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Excretion of 3-Mercaptolactate-Cysteine
Disulfide, Sulfate and Taurine in human Urine
before and after Oral Administration of
Sulfur-containing Amino Acids.∗
Shigeki Yuasa, Reiko Akagi, Toshihiko Ubuka, Noriyoshi Masuoka, and
Kenzaburoh Yao
Abstract
The excretion of 3-mercaptolactate-cysteine mixed disulfide [S-(2-hydroxy-2-carboxyethylthio)-
L-cysteine, HCETC], sulfate and taurine in the urine of normal adults was investigated before and
after oral administration of L-cysteine and related sulfur-containing amino acids. Before the load-
ing of amino acids, the excretion (mean +/- SD) per kg of body weight per day of HCETC, free
sulfate and taurine was 0.096 +/- 0.042, 305.7 +/- 66.1 and 31.9 +/- 8.7 mumols, respectively.
After the loading of L-cysteine (800 mumols/kg of body weight), the average excretion in the 24-h
urine of HCETC increased 2-fold and that of taurine increased 1.6-fold. The average excretion
of free sulfate after the L-cysteine loading was 989.4 +/- 145.1 and 388.8 +/- 51.6 mumols/kg
per day in the first and second 24-h urine, respectively, indicating that the sulfur corresponding
to 85% of the L-cysteine loaded was excreted as free sulfate in 24 h. Administration of L-cystine
(400 mumols/kg) resulted in similar results. The increase in HCETC after L-cysteine or L-cystine
administration indicates that L-cysteine is metabolized in part through the transamination pathway
(3-mercaptopyruvate pathway) and that an equilibrium exists between the intake and excretion of
sulfur in humans.
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